Manufacturers Life Insurance Company, The Nektar Therapeutics Transaction History
Manufacturers Life Insurance Company, The
- $109 Billion
- Q4 2024
A detailed history of Manufacturers Life Insurance Company, The transactions in Nektar Therapeutics stock. As of the latest transaction made, Manufacturers Life Insurance Company, The holds 65,071 shares of NKTR stock, worth $58,563. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,071
Previous 66,218
1.73%
Holding current value
$58,563
Previous $86,000
30.23%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding NKTR
# of Institutions
153Shares Held
131MCall Options Held
92.7KPut Options Held
4.9K-
Black Rock Inc. New York, NY15.2MShares$13.6 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.3MShares$11.1 Million0.0% of portfolio
-
Samlyn Capital, LLC New York, NY9.67MShares$8.7 Million0.14% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT7.81MShares$7.03 Million0.37% of portfolio
-
Acadian Asset Management LLC Boston, MA7.2MShares$6.48 Million0.02% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $169M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...